InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.25
(
0.00%
)
Bitcoin
90,858.47
(
0.31%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1063
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 61

Saturday, 03/17/2018 10:16:44 AM

Saturday, March 17, 2018 10:16:44 AM

Post# of 438
BLCM will be re-set when the BPX 501 clinical hold is resolved

BPX 501 protocol changes have already been submitted to the FDA: http://ir.bellicum.com/news-releases/news-release-details/bellicum-pharmaceuticals-provides-operational-update-and-3

Curiously, no BPX 501-related encephalopathy have been reported in the European registration study.

Reported positive interim Ph2 open label data in pediatric patients with acute AML & primary immunodeficiency 3/18.

Cash runway can be stretced thru Q1,2019

I speculate that dilution will occur not long after the lifting of the clinical hold.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up